2025/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | |
Insurance Revenue | 10,463,000 | 10.497% | 9,469,000 | 8,352,000 | -- | -- |
Interest Income | 3,882,000 | -2.118% | 3,966,000 | 3,852,000 | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | -- | 8,242,000 | 18,609,000 |
Net Premium Income | -- | -- | -- | -- | 7,901,000 | 17,248,000 |
Investment Income/(Loss) | 1,700,000 | 38.549% | 1,227,000 | 3,608,000 | (230,000) | 4,304,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | -- | 1,056,000 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | -- | 1,025,000 |
Other Income/(Loss) | 238,000 | 12.264% | 212,000 | 203,000 | 194,000 | 561,000 |
Total Revenues | 16,283,000 | 9.473% | 14,874,000 | 16,015,000 | 7,865,000 | 24,194,000 |
Insurance Service Expenses | (6,544,000) | 5.175% | (6,222,000) | (5,344,000) | -- | -- |
Net Expenses from Reinsurance Contracts | (292,000) | 32.127% | (221,000) | (202,000) | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | (4,969,000) | 51.540% | (3,279,000) | (6,313,000) | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | 54,000 | -11.475% | 61,000 | 55,000 | -- | -- |
Net Impairment Loss | (36,000) | -- | 1,000 | (47,000) | -- | -- |
Other Expenses | (1,664,000) | 15.156% | (1,445,000) | (1,441,000) | (5,953,000) | (20,482,000) |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
Share of results of Associates & JCEs | 273,000 | 273.973% | 73,000 | (102,000) | (115,000) | 2,000 |
Profit / (Loss) before Taxation | 3,105,000 | -19.183% | 3,842,000 | 2,621,000 | 1,797,000 | 3,714,000 |
Taxation | (556,000) | 6.513% | (522,000) | (366,000) | (249,000) | (445,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (15,000) | 150.000% | (6,000) | (5,000) | (5,000) | (24,000) |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 2,534,000 | -23.537% | 3,314,000 | 2,250,000 | 1,543,000 | 3,245,000 |
2025/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2024/06 USD(K$) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | |
Depreciation & Amortisation | 241,000 | 7.111% | 225,000 | 193,000 | 193,000 | 194,000 |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
EPS (cts) | 24.000 | -18.727% | 29.530 | 19.390 | 12.830 | 26.900 |
DPS (cts) | 6.275 | -- | 5.711 | 5.394 | 5.134 | 4.881 |
Dividend Payout Ratio (%) | 26.144% | -- | 19.339% | 27.818% | 40.017% | 18.146% |
Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
NBV per share ($) | 3.811 | -- | 3.515 | 3.607 | -- | 4.873 |
Remarks: | Real time quote last updated: 22/08/2025 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K$) | USD 2,534,000 |
%Change | -23.537% |
EPS / (LPS) | USD 0.240 |
NBV Per Share ($) | USD 3.811 |